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ABSTRACT
In the present study, neutrophil functions were exam-
ined in vitro in 35 patients (15 men and 20 women;
mean age 38 years) suffering from perennial allergic
rhinitis. Adherence to nylon, serum chemotaxis and
phagocytosis–bactericidal activity were assayed. A
Candida albicans strain was used for the experiments
of phagocytosis–bactericidal activity. Adherence to
patients’ neutrophils was found in normal patients
(22.6 ± 1.89%) and healthy controls (26.1 ± 1.59%; 
P > 0.05). In contrast, the chemotactic ability of 
the patients’ sera was inferior to that of healthy 
control patients (leucotactic index 20.25 ± 0.76 
vs 28.04 ± 0.46 µm, respectively; P < 0.0001).
Patients’ neutrophils phagocytosed 102.77 ± 6.03
microorganisms per 100 cells, while controls phago-
cytosed 138.05 ± 7.60 microorganisms per 100 cells
(P < 0.001). Bactericidal activity was also severely
impaired in patients compared with controls
(17.19 ± 1.67 vs 33.23 ± 1.96%, respectively;
P < 0.0001). The observed host defense disorders
provide additional information that helps to explain
the increased susceptibility of these patients to bacter-
ial infections.
Key words: atopy, host defense, neutrophils, perenni-
al allergic rhinitis.
INTRODUCTION
Allergic rhinitis is common. It is mainly found in atopic
individuals. Between 10 and 20% of the US population is
affected.1 Perennial allergic rhinitis (PAR) is due to aller-
gens that are present throughout the year. Perennial nasal
symptoms indicate chronic allergy due to indoor factors.
Numerous studies have been performed over the past
few years investigating the interrelationship of host defense
mechanisms and atopy. However, evidence of neutrophil
involvement in allergic rhinitis has been circumstantial.2
Nevertheless, there is evidence that there is an impair-
ment of neutrophil function in PAR patients. Neutropenic
subjects suffer from chronic (perennial) rhinitis 3.4-fold
more frequently than non-neutropenics.3 Other authors
consider that persistent inflammation may further lead to the
dysregulation of local cellular immunity by reducing the
number and activity of neutrophils on the mucosal surface.4
Secondary infections of sinuses and the middle ear are
commonly found in this type of allergic rhinitis.5,6 It is not
yet known whether atopy itself affects the function of
neutrophils as a result of the participation of neutrophils
in a chronic inflammatory procedure, rendering patients
more susceptible to infections, or whether infections
occur only on the basis of anatomic and physiologic
alterations caused by allergic rhinitis. The study of neutro-
phils in atopic subjects is potentially important for at least
two reasons. First, the neutrophil is used as an available
model cell, in which general characteristics of tissue
responsiveness can be assessed. Second, the release of
toxic substances by neutrophils may contribute to the
morbidity of allergic disease.7 Therefore, in the present
study, we examined neutrophil functions in patients suffer-
ing from PAR without any other health problem and who
had no symptoms when they were tested.
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METHODS
Patients
Thirty-five patients (15 men and 20 women; mean age
38 years, range 21–54 years) suffering from PAR, with no
other health problems, were included in the study.
Diagnosis was based on history data and on clinical find-
ings, as well as a positive response to intradermal skin
tests (patients were allergic to mite allergens). One month
before the study and during the study, there were no
symptoms and no medication was administered. There
was not any clinical or laboratory evidence of infection
for the same period. All patients had reported frequent
episodes of atopic symptomatology in the past.
The comparison group consisted of 35 healthy volun-
teers paired for age (mean 38 years, range 20–58 years)
and sex (15 men and 20 women).
Neutrophil preparation
Heparinized blood was mixed with 6% dextran in 0.15%
mol/L NaCl. Erythrocytes were sedimented at room tem-
perature for 45 min. The leukocyte-rich supernatant was
centrifuged to obtain a pellet of leukocytes. This was
washed twice in RPMI medium 1640 (Gibco, Grand Island,
NY, USA) and layered onto Ficoll–Hypaque (Pharmacia,
Piscataway, NJ, USA) gradient. Following separation,
polymorphonuclear leukocytes were suspended in the
same medium at a concentration of approximately
10 000 cells/mL.8 By microscopy, the preparation con-
tained less than 5% mononuclear cell contamination and
neutrophils made up more than 90% of the sample.
Viability exceeded 98% as assessed by trypan blue dye
exclusion. The percentage of eosinophils in our patients
when the tests were performed was 6 ± 2%, while in the
healthy controls it was 2 ± 2%.
Adherence to nylon
Adherence of neutrophils to nylon was assayed by a
minor modification of the method of McGregor et al.9
Briefly, 60 mg 12 mm columns of nylon fiber (3 denier,
4 cm; type 200; Fenwal Laboratories, Morton Groove,
IL, USA) were constructed in Pasteur pipettes. The fiber
was packed by means of a wooden applicator stick in the
pipette. The columns were not washed or flushed with any
fluid before use. Aliquots (1 mL) of the neutrophil suspen-
sion were filtered through the three columns, which had
been warmed previously to 37°C in an incubator.
Adherence was calculated by averaging the percentage
of neutrophils retained in these columns.
Chemotaxis
The chemotactic assay was performed with the modified
acrylic Boyden chambers (Alcho, Southington, CT, USA),
as described previously.10 Boyden chambers consist of
two compartments, the upper and lower, separated by a
micropore filter (MF filters; Millipore, Bedford, MA, USA).
The neutrophil suspension is placed in the upper com-
partment and the chemoattractant in the lower. The
chamber is incubated for 90 min at 37°C and the filter is
then removed, fixed and stained with hematoxylin. To
evaluate the results, cells are counted at 10 µm intervals
starting from the proximal filter surface and the average
distance traveled by cells (leucotactic index, LI) is calcu-
lated. In our experiments, the chemoattractive ability of
the subjects’ sera was tested on normal neutrophils
derived from a young healthy volunteer. Serum was acti-
vated by the addition of 5 mg/mL Zymosan (Sigma
Chemical Co., St Louis, MO, USA) and subsequent agi-
tation for 30 min at 37°C. Control experiments in which
no chemoattractant was used were run concurrently.
Phagocytosis and bactericidal function
The phagocytic and bactericidal functions of neutrophils
were assayed as described by Smith and Rommel.11
Candida albicans was selected as the test microorgan-
ism. The strain used was isolated from urine cultures
taken from patients with asymptomatic urinary tract infec-
tion and was sensitive to the usual antibiotics. Candida
albicans was harvested after three days’ culture in
Sabouraud medium. Microorganisms were suspended in
10 mL phosphate-buffered saline (PBS) and washed three
times with PBS by centrifugation and then resuspended in
PBS at a concentration of 106 microorganisms/mL, as
determined spectrophotometrically. Six drops of freshly
drawn non-anticoagulated whole peripheral venus blood
were placed on a glass coverslip and incubated in a
humidity chamber at 37°C. After 45 min, the clot was
removed and the glass coverslip was gently rinsed with
RPMI 1640. The glass coverslip with the adherent phago-
cytes was then flooded with 1.8 mL bacterial suspension
and 0.2 mL autologus serum, followed by a second incu-
bation at 37°C for 45 min. Finally, the glass coverslip was
stained with acridine orange fluorochrome stain (Fisher
Scientific, Springfield, NJ, USA). Stained viable bacteria
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appear green, whereas non-viable bacteria appear red
when viewed by fluorescence microscopy. Adhering bac-
teria can be distinguished from phagocytosed bacteria
because they lose their fluorescence with crystal violet
stain. Two different glass coverslips for each subject were
assayed; 50 phagocytic cells were counted each time.
The mean number of phagocytosed bacteria per cell and
the percentage of non-viable to phagocytosed bacteria
was then calculated.
Statistical analysis
Data were analyzed using two-tailed Student’s t-test. Due
to the fluctuation of the phagocytic activity of the neutro-
phils of various individuals, a paired t-test was used for
the phagocytosis assay.
RESULTS
Adherence
There were no pathologic findings relative to the adher-
ence of neutrophils to nylon. The mean (±SEM) adherence
of the patients’ neutrophils was 22.6 ± 1.89% compared
with 26.1 ± 1.59% for the control group (P > 0.05;
Fig. 1).
Serum chemotaxis
When Zymosan-activated serum from the control group
was used as the chemoattractant, the mean distance 
traveled by neutrophils (LI) was 28.04 ± 0.46 µm,
whereas in the case of the patients the LI was
20.25 ± 0.76 µm. These results demonstrate that patients’
sera had a significantly lower chemotactic effect on
normal neutrophils (P < 0.001; Fig. 2).
Phagocytosis
The phagocytic ability of the patients’ neutrophils was
severely impaired compared with that of healthy controls.
The mean number of bacteria ingested per neutrophil in
the control group was 138.05 ± 7.6 per 100 cells, while
patients’ neutrophils ingested 102.77 ± 6.03 micro-
organisms per 100 cells (P < 0.001; Fig. 3).
Bactericidal function
The percentage of ingested bacteria killed by the neutro-
phils was also reduced in the patient group. Neutrophils
from the control group killed 33.23 ± 1.96% of C. albi-
cans, whereas neutrophils derived from patients killed
17.19 ± 1.67% (P < 0.001; Fig. 4).
DISCUSSION
Almost everyone agrees that atopic conditions, such as
allergic rhinitis and asthma, include an inflammatory
process. The main function of the neutrophils is the
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Fig. 1 Percentage of neutrofils adhering to nylon fibers in
healthy subjects () and patients ().
Fig. 2 Neutrophil chemotactic index in controls () and
patients ().
Fig. 3 Neutrophil phagocytosis in controls () and patients
().
support of non-specific host defense mechanisms. The
inflammatory response during allergic airway inflam-
mation involves the recruitment of multiple leukocyte
populations, which includes neutrophils, monocytes, lym-
phocytes and eosinophils. All these populations likely
contribute to the pathology observed during repeated
episodes of allergic inflammation.12 The extent of the
inflammatory reaction determines the seriousness of the
allergic disease.13
Our results demonstrate that adherence to nylon of the
peripheral blood neutrophils from patients with PAR who
were in a quiescent (symptomless) interval was normal.
The regulation of epithelial cell adhesion molecules is
considered to be cytokine orchestrated in both seasonal
allergic rhinitis and PAR.14 Intercellular adhesion mole-
cule (ICAM)-1 expression on epithelial cells occurs as an
early event (30 min after allergen-specific challenge) and
persists up to 48 h.15 Moreover, Frew et al. have estab-
lished that, in asthmatics, there was no significant
endothelial expression after local endobronchial allergen
challenge of P-selectin, E-selectin, ICAM-1 or vascular
cell adhesion molecule-1 when 24 h had elapsed. There
was also no significant difference in neutrophils in the
submucosa.16
The identity of the migrating leukocytes in an inflam-
matory procedure varies depending on the nature of the
inciting stimulus and also changes as the inflammatory
site ages (neutrophils predominate for the first 6–24 h).17
According to the mentioned above, we assume that the
interpretation of normal adherence is based on the fact
that our experiments took place when patients were in a
latent phase, with no exacerbation of the inflammatory
process.
Studies regarding increased chemotactic activity of
neutrophils in allergic rhinitis and other atopic diseases
were performed after allergen challenge of subjects or
when nasal symptoms were present.18,19 Therefore, the
relevance of patients who are in a quiescent (symptom-
less) interval is uncertain. In contrast, impairment of
neutrophilic chemotaxis has been reported in patients
with other atopic disorders.20 Hakanson et al. studied the
formation of heat-stable and heat-labile neutrophil
chemotactic activity in serum after allergen challenge in
allergic subjects during and after the pollen season. Both
heat-stable and heat-labile activity was significantly
reduced after the pollen season compared with that
before the pollen season. The authors suggested the 
generation of an inhibitor at this period.21 Our serum
chemotaxis experiments, which were performed with
normal neutrophils, indicate that the patients’ serum is
either less functional or contains some type of inhibitor in
accordance with the inhibitor proposed by Hakanson et al.
Our data also suggest a defective phagocytosis and
bactericidal function of neutrophils.
Untreated seasonal allergic rhinitis patients have less
neutrophil phagocytic activity and a decreased count of
Fc receptors.22 Eosinophils in allergic individuals demon-
strate enhanced FcαR expression, whereas neutrophils do
not.23 Mean percentages of polymorphonuclear leuko-
cytes (PMN) and monocytes with Fc and complement
receptors of asthmatic children were significantly lower
than those of normals. Moreover, in allergic patients, the
numbers of PMN with Fc as well as complement receptors
were decreased significantly after incubation with aller-
gen.24 Our data also suggest defective pahagocytosis
and bactericidal function of neutrophils in PAR patients.
Phagocytosis of antibody coated particles and immune
complexes by PMN and macrophages is initiated by
binding to Fc receptors. During chemotaxis, the Fc recep-
tors of human neutrophils are localized to the cell’s
leading edge25 An abnormal regulation or expression of
Fc receptors and complement receptors can partly explain
the functional impairment of neutrophils in our patients.
Myeloperoxidase (MPO) is an enzyme contained in the
azzurophilic granules of neutrophils, which plays a major
role in bacterial killing. Wang et al. have demonstrated
that MPO is not locally elaborated in measurable quanti-
ties during suspected seasonal allergic reactions or
during acute allergen challenges. In addition, they did
not find any significant increase of the MPO concentra-
tion in patients with PAR.26 Xue et al. revealed that MPO
and acid phosphatase (ACP) activities in neutrophils from
patients with atopic disease were significantly decreased.
The results indicate that a primary deficiency of MPO and
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Fig. 4 Percentage of bacteria killed by neutrophils (bacterici-
dal action %) in controls () and patients ().
ACP in the azzurophilic granules of neutrophil exists in
atopy. It was also postulated that MPO and ACP defi-
ciency led to the reduction of the bactericidal power of
neutrophils, as well as the delay of bactericidal action.27
Finally, Pytsky and Filatov have found that blood culti-
vation of sensitized people and animals with specific
allergen caused the phenomenon of specific inhibition
stimulated luminol-dependent chemiluminescence of
leukocytes (PhSISCL). They also assume that PhSISCL is
connected with the inhibition of MPO activity.28 These
data lead us to assume that our experimental observa-
tions of defective phagocytosis and bactericidal function
of neutrophils in PAR patients could be the result of many
factors, such as decreased Fc complement receptors and
a deficiency of MPO and ACP.
In conclusion, our study demonstrates that patients suf-
fering from PAR who were in a quiescent (symptomless)
interval had defective neutrophil function. The observed
host defense disorders provide additional information
that helps us to explain the increased susceptibility of
these patients to bacterial infections. Further studies will
be needed to elucidate the role of neutrophils in the
pathophysiologic process of PAR.
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